Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets EXMKT - Delayed Quote USD

RegenETP, Inc. (RGTPQ)

Compare
0.1600
0.0000
(0.00%)
At close: April 14 at 4:00:00 PM EDT

Key Executives

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Richard Hague President, CEO & Director 479.81k -- 1960
Mr. Nikolai Sopko M.D., Ph.D. COO & Chief Scientific Officer -- -- --
Mr. Rich Haerle Vice President of Investor Relations & Strategy -- -- --
Mr. Mark E. Lehman J.D. Chief Legal Officer -- -- --
Angela Ziegler Vice President of Marketing & Public Relations -- -- --
Mr. Alain Adam Vice President of Sales -- -- --
Dr. Jon Anthony Joseph Burrows B.Sc., M.Sc., Ph.D. Senior VP of Corporate Development & President of Contract Services -- -- 1962
Mr. Ryan Mathis M.D. Chief Medical Officer -- -- --
Mr. Kolby Day Esq. Senior Vice President of Manufacturing Operations -- -- --

RegenETP, Inc.

1960 South 4250 West
Salt Lake City, UT 84104
United States
800 560 3983 https://www.polaritybio.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
42

Description

RegenETP, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and other tissue regeneration products. The company was formerly known as PolarityTE, Inc. and changed its name to RegenETP, Inc. in August 2023. RegenETP, Inc. is headquartered in Salt Lake City, Utah.

Corporate Governance

RegenETP, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

April 16, 2025 at 12:30 PM UTC - April 26, 2025 at 12:30 PM UTC

RegenETP, Inc. Earnings Date

Recent Events

August 18, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 15, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 1, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 10, 2023 at 12:00 AM UTC

25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured

July 7, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 8, 2023 at 12:00 AM UTC

RW: Registration Withdrawal Request

June 7, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 12, 2023 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 26, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 27, 2023 at 12:00 AM UTC

10-K: Periodic Financial Reports

Related Tickers